Mind Medicine Mindmed Inc (MNMD)
$3.44
0.03 (0.88%)
MNMD Stock Quote Delayed 30 Minutes
7 F-Rated Stocks to Sell Before We Reach Christmas
While you’re looking for the perfect holiday bargains to put under the tree, this is also an ideal time to clear your portfolio from F-rated stocks to sell.
11 Best Stocks to Buy for 2023
INSIDE: Investing legend Louis Navellier reveals his Top 11 Stocks for 2023 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
-
PE Ratio
-
EPS
-
Volume (Avg. Vol.)
455,613
Day's Range
$3.35 - $3.55
52-Week Range
$2.12 - $22.20
Dividend & Yield
N/A (N/A)
MNMD Stock Predictions, Articles, and Mind Medicine Mindmed Inc News
Cory Booker Sends MindMed (MNMD) Stock Up 10%
Mind Medicine (MNMD) stock is heating up on Tuesday thanks to tweets from Senator Cory Booker calling for changes to regulations on psychedelics.
Why Is MindMed (MNMD) Stock Plunging 51% Today?
MNMD stock is tumbling more than 50% after the drug maker announced that it would sell shares of its stock and warrants for its shares.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
It's time for another dive into the biggest pre-market stock movers as we check out what's going on on Wednesday morning.
MindMed (MNMD) Stock Regains Nasdaq Compliance
MindMed (MNMD) stock is in the news Wednesday after the psychedelic medicine company regained Nasdaq minimum price compliance.
MindMed (MNMD) Stock Is Up on Psychedelics News
MindMed (MNMD) stock is on the move Wednesday following positive data from a Phase II clinical trial of MM-120 for anxiety.
MindMed (MNMD) Stock Falls After Reverse Stock Split
MindMed's price should be less volatile after its 1-for-15 reverse stock split, making it less interesting to speculators
Dear MNMD Stock Fans, Watch This Key Catalyst
The DEA is abandoning its quest to impose further psychedelic bans. MNMD stock will benefit from this news.
What Is Going on With MindMed (MNMD) Stock Today?
Today, investors in MindMed and MNMD stock are pricing in a number of catalysts, driving the value of this speculative stock higher.
Don’t Get Squeezed Out of Your Money with Mind Medicine Stock
MNMD stock caught the attention of meme stock traders, but subpar fundamentals make it hard to invest in Mind Medicine with confidence.
The Hidden Reason MindMed (MNMD) Stock Is Still Climbing
MindMed (MNMD) stock is a hot topic on Friday as the company's shares continue to rally with investors seeing it as a short-squeeze target.
Is MindMed (MNMD) Stock the Next Big Short Squeeze?
MNMD stock went through a short squeeze overnight, helped by a Cantor Fitzgerald recommendation and hope for LSD as a therapeutic.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
It's time to take a look at the biggest pre-market stock movers for Thursday and the news that's got those shares moving!
Dear Psychedelic Stocks Fans, Watch This Key Catalyst
Psychedelic stocks are in focus following new legislation from both the Senate and the House that has bipartisan support.
FDA Greenlight Sets the Stage for Upside With Mind Medicine
Few catalysts can move healthcare stocks like a regulatory clearance can - and MNMD stock could be 2022's top psychedelics-sector investment.
MNMD Stock: The FDA Go-Ahead That Has MindMed Investors Feeling Euphoric Today
MindMed (MNMD) stock is getting a buzz today thanks to approval from the FDA to move forward with a clinical trial of MM-120.
MNMD Stock: The Latest Psychedelic Drug News MindMed Fans Should Watch
MindMed's LSD trials are facing a regulatory roadblock but MNMD stock isn't being forced down. Here's why investors should watch.
MNMD Stock Pops Higher After MindMed Unveils ‘Psychedelic’ Data
MNMD stock is up today after MindMed reported positive findings on the interactions between psilocybin and an antidepressant.
